Oral immunisation as a strategy for enhancing corneal allograft survival

British Journal of Ophthalmology

Volumn 81, Issue 9, 1997, Pages 778-784

  Ma, Ding ^a   Mellon, Jessamee ^a   Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; MAJOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORNEA CELL; CORNEA ENDOTHELIUM; CORNEA EPITHELIUM; CORNEA TRANSPLANTATION; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY COMPLEX; HISTOCOMPATIBILITY GENE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; TISSUE CULTURE;

EID: 0030707837     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.81.9.778     Document Type: Article

References (30)

1. The Collaborative Corneal Transplantation Studies Research Group. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol 1992;110:1392-403.
2. Williams KA, Roder D, Muehlberg SM, Coster DJ. Factors predictive of corneal graft survival. Ophthalmology 1992;99: 403-14.
3. Lindstrom RL. Advances in corneal transplantation. N Engl J Med 1986;315:57-9.
4. Belin MW, Bouchard CS, Phillips TM. Update on topical cyclosporin A: background, immunology and pharmacology. Cornea 1990;9:184-95.
5. Dupon E, Wybran J, Tonssaint C. Glucocorticosteroids and organ transplantation. Transplantation 1984;37:331-5.
6. Mowat AM. The regulation of immune responses to dietary protein antigens. Immunol Today 1987;8:93-8.
7. Higgins PJ, Weiner HL. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 1988;140:440-5.
8. Nussenblatt RB, Caspi RR, Mahdi R, Chan CC, Roberge F, Lider O, et al. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 1989;144:1689-95.
9. Zhang Z, Lee C, Weiner H. Suppression of adjuvant arthritis by oral administration of type II collagen. J Immunol 1990;145:2489-93.
10. Zhang Z, Davidson L, Elisenbarth G, Weiner H. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991;88: 10252-6.
11. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, et al. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993;259:1321-4.
12. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993;261:1727-30.
13. He Y-G, Mellon J, Niederkorn JY. The effect of oral immunization on corneal allograft survival. Transplantation 1996; 61:920-6.
14. Feder JM, Antonyhsamy MA, Moticka EJ. Oral administration of alloantigens enhances corneal allograft survival. Invest Ophthalmol Vis Sci (Suppl) 1995;36:S1010.
15. He YG, McCulley JP. Growing human corneal epithelium on collagen shield and subsequent transfer to denuded cornea in vitro. Curr Eye Res 1991;10:851-63.
16. Yue BYJT, Sugar J, Gilboy JE, Elvart JL. Growth of human corneal endothelial cells in culture. Invest Ophthalmol Vis Sci 1989;30:248-53.
17. Wilson SE, Weng J, Blair S, He Y-G, Lloyd S. Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated high-proliferative capacity. Invest Ophthalmol Vis Sci 1995;36: 32-40.
18. Benson JL, Niederkorn JY. The presence of donor-derived class II-positive cells abolishes immune privilege in the anterior chamber of the eye. Transplantation 1991;51:834-8.
19. She SC, Steahly LP, Moticka EJ. A method for performing full-thickness, orthotopic, penetrating keratoplasty in the mouse. Ophthalmic Surg 1990;21:781-5.
20. He YG, Ross J, Niederkorn JY. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti CD4 monoclonal antibody. Invest Ophthalmol Vis Sci 1991;32:2723-8.
21. Holland EJ, Chan C-C, Wetzig RP, Palestine AG, Nussenblatt RB. Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratopasty model. Cornea 1991;10:374-80.
22. Rizzo LV, Miller-Riyero NE, Chan C-C, Wiggert B, Nussenblatt RB, Caspi RR. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J Clin Invest 1994;94:1668-72.
23. Sun J-B, Holmgren J, Czerkinsky C. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci (USA) 1994;91:10795-9.
24. Suh EDW, Vistica BP, Chan C-C, Raber JM, Gery I, Nussenblatt RB. Splenectomy abrogates the induction of oral tolerance in experimental autoimmune uveoretinitis. Curr Eye Res 1993;12:833-9.
25. Steinman R. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-96.
26. McKinney EC, Streilein JW. On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo. J Immunol 1989;143:1560-4.
27. Austyn JM, Steinman RM. The passenger leukocyte - a fresh look. Transplant Rev 1988;2:139-76.
28. Klinken WEF, Labadie JH, Bowers WE. Accessory and stimulating properties of dendritic cells and macrophages isolated from various rat tissues. J Exp Med 1982;156:1-19.
29. McKenzie SJ, Halsey JF. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J Immunol 1984;133:1818-24.
30. Elson CO, Ealding W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 1984;132:2736-41.